Company identity
Company number RC000231
Company profile
UK company RC000231, incorporated on 1 January 1981.
Imperial College London
Imperial College London is a world-class university with a mission to benefit society through excellence in science, engineering, medicine and business.
Company number RC000231
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Company registered at Companies House
1 Jul 2026 to 31 Mar 2027
This project addresses a cross-cutting advanced manufacturing supply chain challenge by improving resource efficiency, strengthening domestic materials capability and increasing manufacturing resilience within the UK. The project targets two of the competition's growth-driving sectors Advanced Manufacturing and Clean Energy Technology. The IEA estimates t...
1 Dec 2025 to 30 Nov 2026
When producing parts in metal by 3D printing, also known as additive manufacturing (AM), defects can occur. In common with other manufacturing processes, these defects may consist of cracks, internal pores or impurities, and these defects could lead to premature or unexpected failure of a part. To combat this, inspection and quality assurance processes ar...
1 Nov 2025 to 31 Oct 2029
Project ASCENT (Aerospace Composite Engineering for New Technologies), is a partnership between Rolls-Royce plc, Oxford University, Bristol University and Imperial College London. This project aims to advance state-of-the-art in the use of organic composites in gas turbine fan systems and provides significant understanding to mature Rolls-Royce's UltraFan...
1 Oct 2025 to 31 May 2026
As electricity networks face growing pressure for connections, the need for smarter, faster, and more flexible network solutions becomes essential. Dynamic Rating (DR) allows electricity network assets, particularly overhead lines, to operate closer to their real-time thermal capacity by accounting for environmental conditions. Dynamic, Data Driven Asset ...
1 Jul 2025 to 31 Dec 2026
In colorectal surgery, the surgeon removes the tumour-affected bowel section and reconnects the two healthy bowel ends to form an 'anastomosis'. An insufficient oxygenated blood flow to the reconnected bowel can lead to anastomotic leaks (AL). Patients with AL have the risks: * 19.7% being readmitted for further treatment chance * 19.3% getting an infecti...
1 Jun 2025 to 31 May 2027
A project to develop a highly-sensitive sensor to be deployed in a handheld device for paediatric upper limb therapy. Using novel soft silicon technology, the device will gather data on hand mobility, pinch strength, grip and dexterity in real time, and provide personalised recommendations to improve the quality of clinical therapy.
1 May 2025 to 30 Apr 2027
Contrails are understood to contribute a significant proportion of aviation's overall climate warming impact. All flights utilising fossil fuel emit CO2 proportionally with fuel burn and therefore contribute CO2-related warming evenly with distance flown. Conversely, warming from contrails is attributable to a minority of flights depending on their flight...
1 May 2025 to 31 Oct 2026
**Empowering Vision-Impaired Individuals: Transforming Lives with Cutting-Edge Technology** 43 million people globally, including 340,000 in the UK, live with blindness. 2 million people in the UK suffer from moderate-to-severe visual impairment (VI), affecting individuals' ability to navigate independently and safely and significantly impacting wellbeing...
1 Apr 2025 to 30 Sep 2027
**Airbus recognises that non-CO2 emissions are an important subject for aviation and is already actively working on a large portfolio of projects addressing non-CO2 emissions, their generation and climate impacts.** Airbus will continue its focus on reducing CO2 emissions from aviation, whilst - in collaboration with research institutions, universities an...
1 Feb 2025 to 31 Jan 2027
This project will develop a flexible and scalable RNA-manufacturing process and delivery system for the sustainable manufacture of biologic drugs, with considerably reduced material-use/energy-costs and the need for repurposing or rebuilding facilities. RNA is the medicine platform of the future with many application-types in clinical trial. RNA therapeut...
1 Feb 2025 to 31 Jan 2027
While single-use (SU) systems offer flexibility and reduce the reliance on solvents and steam, they generate approximately 30,000 tonnes of plastic waste annually---a figure expected to double by 2026\. This significant environmental impact underscores the necessity for innovative solutions that maintain the benefits of SU systems while substantially redu...
1 Jan 2025 to 31 Mar 2026
The potential for enhancing innovation in the UK economy through Novel Food's (NF) is significant, as acknowledged by the government in the Pro-innovation Regulation of Technologies Review -- Life Sciences \[1\]. NF's are regulated by the Food Standards Agency (FSA) in the UK. The process for NFs approval demands specialised regulatory and scientific expe...